← All trials
NCT04841993
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 10, 2018
- Primary completion
- Dec 18, 2019
- Completion date
- Feb 28, 2021
- First posted
- Apr 12, 2021
- Last posted
- Apr 12, 2021
- Enrollment
- 43
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Badalona Hospital Germans Trias i PujolLead sponsor
- Badalona Hospital Germans Trias i PujolCollaborator
- Badalona Hospital Germans Trias i PujolOverall official - principal investigator
- Istituto Superiore di SanitàCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.